Navigation Links
Narconon International Presents to the 14th Latin American Congress of Clinical Toxicology and Chemical Safety
Date:10/22/2013

(PRWEB) October 22, 2013

Dr. Anna Zaucha Tagliaferro, Medical Director of Narconon International in Los Angeles, California, and José de Carpio, Narconon Latin American Consultant, presented the theory and methods of the Narconon drug rehabilitation program to an international toxicology conference, held at the Crystal Palace in Guayaquil, Ecuador between 17 and 18 October, 2013. Nearly 600 persons attended the conference in this large port city. The conference covered a broad range chemical and other toxicology subjects, ranging from ecological issues such as agricultural, site contamination, and ecotoxicology to forensics and risk evaluation, to issues of drug rehabilitation and drug toxins.

Dr. Tagliaferro, M.D., originally practiced medicine in Caracas, Venezuela, where she first encountered the issues of drug addicts presenting themselves with all their personal physical and life problems. She began working with Narconon drug rehab centers in the United States when she immigrated some years ago, as a specialist in the Narconon sauna detoxification procedure, and then was invited to come to Narconon International to be its new Medical Director. Dr. Tagliaferro presented the science background, literature, and delivery techniques of Narconon’s sauna sweat out program which helps a recovering drug addict (or anyone else with toxicity issues) to safely and healthfully reduce the body burden of stored drug and other toxic residuals.

She told the congress that the Narconon sauna detox is based on the research of humanitarian L. Ron Hubbard and has been studied across a broad range of applications including helping environmental or other disaster victims such as after the Chernobyl reactor explosion in the Ukraine and the World Trade Center collapse in New York. It has even been tested to help police in Utah who were disabled after being exposed to toxic chemicals in raids on methamphetamine labs. Dr. Tagliaferro presented the treatment procedure -- use of a specific regimen of vitamins and minerals in combination with exercise and repeated episodes of sweating in low-heat, well-ventilated, dry saunas. She demonstrated evidence of many different kinds of gains reported by those who have completed this procedure, including IQ gain, personality changes, and a generally improved sense of well being. In closing, she said that she agreed with the previous Narconon Medical Director, Dr. Megan Shields, who said, after having supervised more than 15,000 persons through this cleansing protocol, "I think that the Hubbard detoxification program is the single greatest advance in addressing the problems of world pollution and drug addiction. It’s the single greatest advance. It’s cheap. It’s simple. And the results are beyond price."

Jose De Carpio is an Ecuadoran national now working with Narconon International. He had earlier returned from the U.S. to Ecuador to introduce to some of its drug rehab centers the Narconon First Step Program, a method using nutrition and simple assists and exercises to help addicts withdraw from drugs more rapidly and less painfully and experience less persistent discomfort afterwards. He presented the same First Step methodology to the Toxicology Congress.

Staff are now in training to later open up a Narconon drug rehab center in Ecuador. For some years there has been a Narconon center in Colombia and Argentina as well as several in Mexico, including Narconon Tijuana whose president is Padre Jaime Lares. There are also nearly 200 Twelve Step (Narcotics Anonymous) groups across Mexico now using the Narconon First Step procedure.

Dr. Tagliaferro and Mr. De Carpio are going on from the toxicology conference to consult with health authorities in the Galapagos regarding Narconon help with drug addiction issues.

For more information on the Narconon program or centers anywhere in the world, please visit http://www.narconon.org.

Read the full story at http://www.prweb.com/releases/narconon-at-latinamerica/toxicology-congress/prweb11258468.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
2. Mary Rieser of Narconon Georgia Speaks Out For United Nations International Day Against Drug Abuse
3. Narconon Arrowhead Celebrates Twenty Years of Service to More than Ten Thousand Recovering Addicts
4. Narconon Offers New Tool to Help Families Find Faster Solutions to Addiction
5. Narconon Arrowhead Welcomes International Drug Prevention Specialist Who Brings Message of Hope to Clients
6. Narconon International Pledges Wholehearted Support for Rx Drug Abuse Summit Cause: “Make an Impact”
7. International Narconon Directors Join Parents of Graduates to Celebrate Release of 40 Years of Positive Outcome Studies
8. Narconon Arrowhead Volunteers Provide Enthusiastic Support for Pride in McAlester Celebration
9. Narconon Arrowhead Welcomes Worldwide Management Staff for Inspirational Tour
10. LAPD Singles Out Narconon Drug Prevention and Education for Special Commendation
11. Recent Release of ‘The Narconon Program - 40 Years of Evidence of Recovery’ Reveals Earlier Unfound Narconon Connecticut Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016  EIP ... it has obtained proof-of-mechanism for neflamapimod (previously code ... completed Phase 2a clinical trials that demonstrated significant ... Study 302 (12-week treatment) and Study 303 (6-week ... Clinical Trials in Alzheimer,s Disease (CTAD) scientific conference ...
(Date:12/8/2016)... , Dec. 8, 2016 A Small ... the National Institutes of Health (NIH) to ... University.  The grant will seek to ... head device, which utilizes electromagnetic waves to treat Alzheimer,s ... this novel technology to possibly treat other neurologic disorders ...
Breaking Medicine Technology: